GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹5,881 Cr | ₹6,840 Cr | ₹7,115 Cr | ₹6,709 Cr | ₹6,425 Cr |
What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹5,881 Cr |
Mar2023 | ₹6,840 Cr |
Mar2022 | ₹7,115 Cr |
Mar2021 | ₹6,709 Cr |
Mar2020 | ₹6,425 Cr |
How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹5,881 Cr | -14.03 | |
Mar2023 | ₹6,840 Cr | -3.86 | |
Mar2022 | ₹7,115 Cr | 6.04 | |
Mar2021 | ₹6,709 Cr | 4.42 | |
Mar2020 | ₹6,425 Cr | - |
Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹41,680.9 Cr | -7.3% | -4.8% | 72.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹421,527.0 Cr | -3.8% | -3% | 34.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,037.0 Cr | 0.9% | 0.4% | 53.5% | Stock Analytics | |
CIPLA | ₹116,854.0 Cr | -2.8% | -0.1% | 9.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,746.0 Cr | -2.4% | 5.5% | 17.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,093.9 Cr | -2.4% | -0.3% | 42.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -7.3% |
-4.8% |
72.3% |
SENSEX | -1.8% |
-6.6% |
7.1% |
You may also like the below Video Courses